ea0104p171 | Other (E.g. Education, Teaching) | SFEIES24
Wen Loh Ee
, Gupta Prakhar
, McCreanor Matthew
, Munir Alia
Background: AVP deficiency (AVP-D) or cranial diabetes insipidus (CDI) is a rare condition treated with Desmopressin. A patient safety alert was issued in 2016, following mortalities, with recommendations to implement: Desmopressin as a critical drug, raise awareness among healthcare professionals (HCPs) and has driven the name change.Aim: To assess healthcare professionalsÂ’ knowledge on AVP-D and Desmopressin. To evaluate the effectiveness of a bes...